Skip to main navigation

Skip to content

Pharmaceutical Programs

Pharmaceutical

Rare Cannabinoid Manufacturing

Manufacturing

IR Nav

Investor

About

Corporate

Learn

Learn

Menu

Pharmaceutical Programs

Pharmaceutical

Rare Cannabinoid Manufacturing

Manufacturing

IR Nav

Investor

About

Corporate

Learn

Learn

Media

Media

Media

View more videos and articles

Investor Alerts

Sign up for investor alerts!

Information Request

Send us a request for information

#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Pharmaceutical Programs

Pharmaceutical

Cannabinoids in Development
INM-755 for Epidermolysis Bullosa
INM-088 for Glaucoma
Neurodegenerative Disease
Novel Cannabinoid Analogs

Rare Cannabinoid Manufacturing

Manufacturing

Cannabinoid Manufacturing Expertise
IntegraSyn™ - Cannabinoid Manufacturing
Baymedica Cannabinoid Biosynthesis
Rare Cannabinoid Ingredients

IR Nav

Investor

News Releases
Events
Stock Information
Corporate Governance
Financials & AGM
Filings
Presentations
Media

About

Corporate

Management
Board of Directors
Scientific Advisory Board
Partners and Collaborators
Events Calendar
Careers
Contact

Learn

Learn

What is Cannabinol (CBN)?
What is Epidermolysis Bullosa (EB)?
What is Glaucoma?
Cannabinoid Manufacturing Economics 101
GMP Manufacturing Standards by Product Type
Cannabis Treatments for Glaucoma
Cannabinoid Science
Articles and Videos

© Copyright 2023 InMed Pharmaceuticals Inc.

Legal Nav

Privacy Policy
Terms of Use
Legal Disclaimer

Social icons

Find Us On:
>
>
>